Tango Therapeutics Inc (TNGX) — Cash Flow Quality Index

Latest as of September 2025: -1.95x

Tango Therapeutics Inc (TNGX) has a Cash Flow Quality Index of -1.95x as of September 2025. Operating cash flow of $-30.95 Million is below net income of $15.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Tango Therapeutics Inc to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.95x

Operating CF / Net Income

Operating Cash Flow

$-30.95 Million

USD

Net Income

$15.88 Million

USD

Data as of

Sep 2025

Most recent filing

Annual Cash Flow Quality Index for Tango Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Tango Therapeutics Inc. For live market cap and the full company financial profile, see Tango Therapeutics Inc market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.